The use of hydroxycarbamide in children with sickle cell anemia

Background: Although hydroxycarbamide (hydroxyurea [HU]) has been in use for decades in both adults and child populations with sickle cell disease (SCD), its reported use has remained low in Africa and Nigeria where the largest number of SCD patients reside. Availability, cost, and concerns about sa...

Cijeli opis

Bibliografski detalji

Glavni autori:	Hafsat Rufai Ahmad, Jamilu Abdullahi Faruk, Adekunle Matthew Sobowale, Amos Solomon, Adebiyi Niyi Mustapha, Olufemi Gboye Ogunrinde
Format:	Artigo
Jezik:	Inglês
Izdano:	Wolters Kluwer Medknow Publications 2018-01-01
Serija:	Sahel Medical Journal
Teme:	Africa sickle cell anemia. hydroxycarbamide/hydroxyurea sickle cell disease
Online pristup:	http://www.smjonline.org/article.asp?issn=1118-8561;year=2018;volume=21;issue=4;spage=189;epage=193;aulast=Ahmad
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!